AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

RecruitingNAAges 32 Years - 42 YearsFemaleSunkaky Medical Cooperation
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Agree to participate in the study * 32-42 years old * Having at least one previous embryo implantation failure * History of low Embryo quality at day3 or day5 (according to Veeck's and Gardner's Criteria) * No major uterine or ovarian abnormalities * BMI level 18-25kg/m2 Exclusion Criteria: * Ovarian endometriosis with Chocolate cysts (AFS type 3 and 4) * Patients who have taken different supplements such as coenzyme Q10, vitamin E, carnitine,niacin, nicotinamide, or other vitamin B3-related etc. within the previous month * Any medical contraindication of oocyte retrieval or subsequent procedures * Couples where the husband presents with severe sperm abnormalities * Couples where the husband presents \<5 million/mL motile sperm * Uterine structural anomalies * Polycystic ovaries * Premature ovarian failure * Individuals who need regular medication to treat chronic diseases such as diabetes, hypertension, gout, hyperuricemia, etc. * Individuals who need drug treatment for any mental illness such as epilepsy and depression. * Individuals who suffer from infectious diseases such as hepatitis B, active tuberculosis, AIDS, etc. * Cancer patients or receiving chemo/radiotherapy treatment within the past 3 years.
๐Ÿ’Š

What it tests

  • NMN capsule
  • Placebo
๐Ÿ“

Where

1 site
IVF Namba Clinic, Sankaky Medical Corporation
Osaka, Japan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy